Furthermore, the authors demonstrated that the expression level of this protein shows a negative correlation with the stage of cancer development (AJCC staging), and survival analysis reveals that Barx2 expression level is an independent prognostic factor for NSCLC patients. Here, BARX2 is linked to non-small cell lung carcinoma.